These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 29491315)
1. The Clinical Findings Useful for Driving Safety Advice for Parkinson's Disease Patients. Ando R; Iwaki H; Tsujii T; Nagai M; Nishikawa N; Yabe H; Aiba I; Hasegawa K; Tsuboi Y; Aoki M; Nakashima K; Nomoto M; Intern Med; 2018 Jul; 57(14):1977-1982. PubMed ID: 29491315 [TBL] [Abstract][Full Text] [Related]
2. Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson's Disease Patients Taking Dopaminergic Medication. Murakami H; Momma Y; Nohara T; Mori Y; Futamura A; Sugita T; Ishigaki S; Katoh H; Kezuka M; Ono K; Miller MW; Kawamura M J Parkinsons Dis; 2016; 6(1):209-17. PubMed ID: 26889633 [TBL] [Abstract][Full Text] [Related]
3. Motor vehicle accidents in Parkinson's disease: A questionnaire study. Ueno T; Kon T; Haga R; Nishijima H; Tomiyama M Acta Neurol Scand; 2018 Feb; 137(2):218-223. PubMed ID: 28948617 [TBL] [Abstract][Full Text] [Related]
4. The association between Parkinson's disease symptom side-of-onset and performance on the MDS-UPDRS scale part IV: Motor complications. Bay AA; Hart AR; Michael Caudle W; Corcos DM; Hackney ME J Neurol Sci; 2019 Jan; 396():262-265. PubMed ID: 30537631 [TBL] [Abstract][Full Text] [Related]
5. Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease. Cova I; Di Battista ME; Vanacore N; Papi CP; Alampi G; Rubino A; Valente M; Meco G; Contri P; Di Pucchio A; Lacorte E; Priori A; Mariani C; Pomati S Parkinsonism Relat Disord; 2017 Jan; 34():38-42. PubMed ID: 28029554 [TBL] [Abstract][Full Text] [Related]
6. Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel. Meindorfner C; Körner Y; Möller JC; Stiasny-Kolster K; Oertel WH; Krüger HP Mov Disord; 2005 Jul; 20(7):832-42. PubMed ID: 15726539 [TBL] [Abstract][Full Text] [Related]
8. Neuropsychological deficits associated with driving performance in Parkinson's and Alzheimer's disease. Grace J; Amick MM; D'Abreu A; Festa EK; Heindel WC; Ott BR J Int Neuropsychol Soc; 2005 Oct; 11(6):766-75. PubMed ID: 16248912 [TBL] [Abstract][Full Text] [Related]
9. Wearing off: A complex phenomenon often poorly recognized in Parkinson's disease. A study with the WOQ-19 questionnaire. Pistacchi M; Gioulis M; Sanson F; Marsala SZ Neurol India; 2017; 65(6):1271-1279. PubMed ID: 29133700 [TBL] [Abstract][Full Text] [Related]
10. Clinical correlates of repetitive speech disorders in Parkinson's disease. Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Sato M; Hattori M; Kawabata K; Hara K; Nakatsubo D; Maesawa S; Kajita Y; Katsuno M; Sobue G J Neurol Sci; 2019 Jun; 401():67-71. PubMed ID: 31029883 [TBL] [Abstract][Full Text] [Related]
11. Differential progression of motor impairment in levodopa-treated Parkinson's disease. Goetz CG; Stebbins GT; Blasucci LM Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412 [TBL] [Abstract][Full Text] [Related]
12. [Motor levodopa-induced complications in Parkinson's disease]. Michałowska M; Fiszer U; Szatanowski T Pol Merkur Lekarski; 2016 Jun; 40(240):357-61. PubMed ID: 27403901 [TBL] [Abstract][Full Text] [Related]
13. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the driving ability in patients with Parkinson's disease using a driving simulator. Thiri Kyaw W; Nishikawa N; Moritoyo T; Tsujii T; Iwaki H; Nomoto M Intern Med; 2013; 52(8):871-6. PubMed ID: 23583990 [TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital. Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818 [TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics in Parkinson's disease patients with cognitive impairment and effects of cognitive impairment on sleep]. Gong Y; Xiong KP; Mao CJ; Huang JY; Hu WD; Han F; Chen R; Liu CF Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2637-41. PubMed ID: 24360043 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease. Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947 [TBL] [Abstract][Full Text] [Related]
19. Effects of dopaminergic treatment on bladder function in Parkinson's disease. Winge K; Werdelin LM; Nielsen KK; Stimpel H Neurourol Urodyn; 2004; 23(7):689-96. PubMed ID: 15382192 [TBL] [Abstract][Full Text] [Related]
20. Profiling the most elderly parkinson's disease patients: Does age or disease duration matter? Virameteekul S; Phokaewvarangkul O; Bhidayasiri R PLoS One; 2021; 16(12):e0261302. PubMed ID: 34937068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]